Tags

Type your tag names separated by a space and hit enter

Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study.
Int J Urol. 2011 Nov; 18(11):778-84.IJ

Abstract

OBJECTIVE

We have recently developed the core lower urinary tract symptom score (CLSS) questionnaire to readily address 10 important lower urinary tract symptoms (LUTS). The aim of the present study was to evaluate the performance of the CLSS in women compared with the International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS).

METHODS

Three hundred and eighteen treatment-naïve consecutive female patients, including 48 controls, completed the three questionnaires. Quality of life (QOL) was determined as per the IPSS QOL Index. The clinical diagnoses were overactive bladder (n = 69), mixed incontinence (n = 42), stress incontinence (n = 17), pelvic organ prolapse (n = 56), interstitial cystitis (n = 31), bacterial cystitis (n = 16), underactive bladder (n = 16), and "other" (n = 23). Simple statistics and the relationship between symptom scores and poor QOL (QOL Index ≥ 4) were examined.

RESULTS

All symptom scores were significantly increased in symptomatic women. The CLSS described the symptom profiles of patients with distinct conditions. The scores of corresponding symptoms on the three questionnaires were significantly correlated (r = 0.51-0.85; all P < 0.0001). Multivariate logistic regression modeling proved five CLSS symptoms (daytime frequency, nocturia, urgency incontinence, straining, and urethral pain) as independent predictors of poor QOL, with hazard ratios ranging from 2.0 to 4.2. The IPSS included only two (urgency and straining) significant symptoms.

CONCLUSIONS

The IPSS alone does not fully evaluate female LUTS, with a possible negative impact on QOL. Using the CLSS questionnaire would enable a simple and comprehensive assessment of female LUTS.

Authors+Show Affiliations

Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. fujimurat-uro@h.u-tokyo.ac.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

21951201

Citation

Fujimura, Tetsuya, et al. "Core Lower Urinary Tract Symptom Score (CLSS) for the Assessment of Female Lower Urinary Tract Symptoms: a Comparative Study." International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 18, no. 11, 2011, pp. 778-84.
Fujimura T, Kume H, Tsurumaki Y, et al. Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study. Int J Urol. 2011;18(11):778-84.
Fujimura, T., Kume, H., Tsurumaki, Y., Yoshimura, Y., Hosoda, C., Suzuki, M., Fukuhara, H., Enomoto, Y., Nishimatsu, H., & Homma, Y. (2011). Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study. International Journal of Urology : Official Journal of the Japanese Urological Association, 18(11), 778-84. https://doi.org/10.1111/j.1442-2042.2011.02848.x
Fujimura T, et al. Core Lower Urinary Tract Symptom Score (CLSS) for the Assessment of Female Lower Urinary Tract Symptoms: a Comparative Study. Int J Urol. 2011;18(11):778-84. PubMed PMID: 21951201.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study. AU - Fujimura,Tetsuya, AU - Kume,Haruki, AU - Tsurumaki,Yuzuri, AU - Yoshimura,Yasukuni, AU - Hosoda,Chihiro, AU - Suzuki,Motofumi, AU - Fukuhara,Hiroshi, AU - Enomoto,Yutaka, AU - Nishimatsu,Hiroaki, AU - Homma,Yukio, Y1 - 2011/09/23/ PY - 2011/9/29/entrez PY - 2011/9/29/pubmed PY - 2012/3/31/medline SP - 778 EP - 84 JF - International journal of urology : official journal of the Japanese Urological Association JO - Int J Urol VL - 18 IS - 11 N2 - OBJECTIVE: We have recently developed the core lower urinary tract symptom score (CLSS) questionnaire to readily address 10 important lower urinary tract symptoms (LUTS). The aim of the present study was to evaluate the performance of the CLSS in women compared with the International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS). METHODS: Three hundred and eighteen treatment-naïve consecutive female patients, including 48 controls, completed the three questionnaires. Quality of life (QOL) was determined as per the IPSS QOL Index. The clinical diagnoses were overactive bladder (n = 69), mixed incontinence (n = 42), stress incontinence (n = 17), pelvic organ prolapse (n = 56), interstitial cystitis (n = 31), bacterial cystitis (n = 16), underactive bladder (n = 16), and "other" (n = 23). Simple statistics and the relationship between symptom scores and poor QOL (QOL Index ≥ 4) were examined. RESULTS: All symptom scores were significantly increased in symptomatic women. The CLSS described the symptom profiles of patients with distinct conditions. The scores of corresponding symptoms on the three questionnaires were significantly correlated (r = 0.51-0.85; all P < 0.0001). Multivariate logistic regression modeling proved five CLSS symptoms (daytime frequency, nocturia, urgency incontinence, straining, and urethral pain) as independent predictors of poor QOL, with hazard ratios ranging from 2.0 to 4.2. The IPSS included only two (urgency and straining) significant symptoms. CONCLUSIONS: The IPSS alone does not fully evaluate female LUTS, with a possible negative impact on QOL. Using the CLSS questionnaire would enable a simple and comprehensive assessment of female LUTS. SN - 1442-2042 UR - https://www.unboundmedicine.com/medline/citation/21951201/Core_lower_urinary_tract_symptom_score__CLSS__for_the_assessment_of_female_lower_urinary_tract_symptoms:_a_comparative_study_ L2 - https://doi.org/10.1111/j.1442-2042.2011.02848.x DB - PRIME DP - Unbound Medicine ER -